| Name | Title | Contact Details |
|---|
There are approximately 7,000 rare disorders worldwide. Each day more are being discovered. 95% of rare diseases have not one single FDA approved treatment. Glycomine develops therapeutics for diseases which have no treatment options.
Decoding the dark matter of the human genome to uncover novel ways to treat disease Discover More
Tactiva is an immuno-oncology company based in Buffalo, New York, utilizing an innovative, dual T cell receptor (TCR) approach to adoptive T cell therapy.
Our mission is to enable novel biological insights at the single-cell level for improved diagnosis and treatment of disease.
ReproSource is a Bedford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.